ATP induces dephosphorylation of myosin light chain in endothelial cells

T. Noll, M. Schäfer, U. Schavier-Schmitz, and H. M. Piper

Physiologisches Institut, Justus-Liebig-Universität, D-35392 Giessen, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In cultured porcine aortic endothelial monolayers, the effect of ATP on myosin light chain (MLC) phosphorylation, which controls the endothelial contractile machinery, was studied. ATP (10 µM) reduced MLC phosphorylation but increased cytosolic Ca2+ concentration ([Ca2+]i). Inhibition of the ATP-evoked [Ca2+]i rise by xestospongin C (10 µM), an inhibitor of the inositol trisphosphate-dependent Ca2+ release from endoplasmic reticulum, did not affect the ATP-induced dephosphorylation of MLC. MLC dephosphorylation was prevented in the presence of calyculin A (10 nM), an inhibitor of protein phosphatases PP-1 and PP-2A. Thus ATP activates MLC dephosphorylation in a Ca2+-independent manner. In the presence of calyculin A, MLC phosphorylation was incremented after addition of ATP, an effect that could be abolished when cells were loaded with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (10 µM). Thus ATP also activates a Ca2+-dependent kinase acting on MLC. In summary, ATP simultaneously stimulates a functional antagonism toward both phosphorylation and dephosphorylation of MLC in which the dephosphorylation prevails. In endothelial cells, ATP is the first physiological mediator identified to activate MLC dephosphorylation by a Ca2+-independent mechanism.

adenosine 5'-triphosphate; myosin light chain phosphorylation; protein phosphatases


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ENDOTHELIAL CELLS POSSESS a contractile apparatus, resembling the one found in smooth muscle cells (18, 27). They contain the contractile elements actin and myosin and accompanying regulatory proteins (18). Phosphorylation of the regulatory myosin light chain (MLC) leads to activation of the endothelial contractile elements (26). An important second messenger regulating MLC phosphorylation is cytosolic Ca2+ concentration ([Ca2+]i); this controls the activity of endothelial Ca2+/calmodulin-dependent MLC kinase (23, 26, 27). It has been shown that mediators like thrombin (6, 19) and histamine (12, 13) can cause hyperpermeability of the endothelial barrier by eliciting an increase in MLC phosphorylation and endothelial cell contraction via a receptor-mediated transient rise in cytosolic Ca2+ (6, 20). Endothelial cells also express protein phosphatases PP-1 and PP-2A (3, 10, 24), which can also influence the phosphorylation state of MLC. We and others showed that inhibition of these protein phosphatases leads to hyperpermeability of the endothelial barrier (3, 10, 24). At present, little is known about the functional antagonism between MLC kinase and myosin phosphatases when these are stimulated simultaneously in endothelial cells.

We found recently (16) that the purine receptor agonist ATP causes a transient rise in [Ca2+]i and yet a reduction of barrier permeability in endothelial monolayers, derived from different mammalian species and vascular provinces such as porcine aorta, porcine pulmonary artery, bovine aorta, and human umbilical vein. The effects were specific for the nucleotide and could not be imitated by adenosine. The observations have suggested that, in endothelial cells, ATP simultaneously activates the antagonistic mechanisms controlling the phosphorylation state of MLC, i.e., a Ca2+-dependent protein kinase and a Ca2+-independent protein phosphatase acting on MLC. The present study was undertaken to analyze these mechanisms in intact endothelial cells. The results demonstrate that ATP predominantly activates dephosphorylation of MLCs. ATP is the first physiological mediator for which such a Ca2+-independent activation has been shown in endothelial cells.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell cultures. Endothelial cells from porcine aorta were isolated and cultured as previously described (25). Confluent cultures of primary endothelial cell were trypsinized in phosphate-buffered saline [composed of (in mM) 137 NaCl, 2.7 KCl, 1.5 KH2PO4, and 8.0 Na2HPO4, at pH 7.4, supplemented with 0.05% (wt/vol) trypsin, and 0.02% (wt/vol) EDTA] and seeded at a density of 7 × 104 cells/cm2 on either 24-mm round polycarbonate filters (pore size of 0.4 µm), 25-mm round glass coverslips, or 30-mm culture dishes for determination of albumin permeability, [Ca2+]i level, or MLC phosphorylation, respectively. Experiments were performed with confluent endothelial passage 1 monolayers 4 days after seeding.

Experimental protocols. The basal medium used in incubations was modified Tyrode solution (composition in mM: 150 NaCl, 2.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.0 CaCl2, and 30.0 HEPES; pH 7.4, 37°C) supplemented with 5% (vol/vol) heat-inactivated newborn calf serum (10 min, 60°C). Basal MLC phosphorylation was determined after an initial equilibration period of 10 min. Agents were added as indicated. Stock solution of ATP was prepared with basal medium immediately before use. Stock solutions of calyculin A, ML-7, xestospongin C, and 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA)-AM were prepared with dimethyl sulfoxide (DMSO). Appropriate volumes of these solutions were added to the cells, yielding final solvent concentrations <= 0.1% (vol/vol). The same final concentrations of DMSO were also included in all respective control experiments. Stock solutions of all other substances were prepared in basal medium (composition as described above). Appropriate volumes of these solutions were added to the cells. Identical additions of basal medium were included in all respective control experiments.

Free [Ca2+]i. [Ca2+]i was determined with the use of the fluorescent Ca2+ indicator fura 2. Confluent endothelial monolayers cultured on round glass coverslips were incubated in medium 199 supplemented with 5% (vol/vol) heat-inactivated newborn calf serum and addition of 5 µM fura 2-AM (acetoxymethyl ester of fura 2) at 20°C in the dark. After a 50-min incubation, extracellular fura 2-AM was removed by medium change. This was followed by a 20-min incubation period in the same medium before measurements were started. The coverslips were then mounted in a fluorescence microscope (IX 70; Olympus, Hamburg, Germany). [Ca2+]i was analyzed using a TILL Photonics (Martinsried, Germany) imaging system. During incubations, the excitation wavelength was alternated between 340 and 380 nm (bandwidth of 8 nm). Emitted light was detected at 510 nm. Fura 2 fluorescence was calibrated according to the method described by Grynkiewicz et al. (8). For this purpose, the cells were exposed to 5 µM ionomycin in modified Tyrode solution containing either 3 mM Ca2+ or 5 mM EGTA to obtain the maximum (Rmax) and the minimum (Rmin) of the ratio of fluorescence, respectively. [Ca2+]i was calculated according to the equation
[Ca<SUP><IT>2+</IT></SUP>]<SUB>i</SUB><IT>=K</IT><SUB>d</SUB><IT>×&bgr;×</IT>(R<IT>−</IT>R<SUB>min</SUB>)/(R<SUB>max</SUB><IT>−</IT>R)
with use of Kd, the dissociation constant of fura 2 (8), and beta , the ratio of the 380-nm excitation signals of ionomycin-treated cells at 5 mM EGTA and at 3 mM Ca2+.

Determination of MLC phosphorylation. The phosphorylation of MLC was determined by glycerol-polyacrylamide gel electrophoresis and immunoblot analysis using an anti-MLC antibody as described previously (17). Cells cultured on 30-mm dishes were incubated as indicated in the text. After pretreatment, the incubation medium was rapidly removed and the reaction was terminated by addition of ice-cold trichloroacetic acid (1.2 mM). Precipitated proteins were transferred into Eppendorf reaction tubes and centrifuged for 10 min at 14,000 g at 4°C. The sediments were washed two times with ice-cold diethyl ether. After evaporation of the ether at room temperature, the sediments were suspended in 30 µl of lysis buffer (8.8 M urea, 10 mM dithiothreitole, 5 mM thioglycolate, 0.6 mM phenylmethylsulfonyl fluoride, 10 µM cantharidin, 60 mM imidazol, 20 mM Tris, and 23 mM glycine, pH 8.8). The lysate was centrifuged at 14.000 g for 5 min. Afterward, 30 µl of a saturated sucrose-bromphenol blue solution were added and 10 µl of lysate (20-40 µg protein) per lane were run at 400 V and 18°C on a 10% polyacrylmamide-40% glycerol gel. Before the lysates were loaded, preelectrophoresis was performed at 400 V for 1.5 h. This procedure allows separation of nonphosphorylated MLCs from the phosphorylated ones, the latter of which migrate more rapidly under this condition. Electrophoretically separated proteins were transblotted on polyvinylidene difluoride membranes and were incubated with an anti-MLC antibody (clone MY-21, Sigma Chemical, Deisenhofen, Germany) followed by an alkaline phosphatase-coupled second antibody as previously described (14). The blots were scanned, and the percentage of MLC phosphorylation (expressed as percentage of total MLC) was calculated from the blot areas of non- (MIC), mono- (MLC-P), and diphosphorylated MLC (MLC ~ PP) as follows
MLC phosphorylation<IT> = </IT><FR><NU>(<IT>2×</IT>MLC∼PP) + MLC ∼ P</NU><DE>total MLC</DE></FR><IT> ×100</IT>
Because MLC can become diphosphorylated, MLC phosphorylation varies between 0 and 200%.

Materials. Falcon plastic tissue culture dishes were from Becton Dickinson (Heidelberg, Germany); ATP was from Boehringer (Mannheim, Germany); BAPTA-AM, calyculin A, ML-7, and xestospongin C were from Calbiochem (Bad Soden, Germany); Transwell polycarbonate filter inserts (24 mm diameter, 0.4 µm pore size) were from Costar (Bodenheim, Germany); newborn calf serum, medium 199, penicillin-streptomycin, and trypsin-EDTA were from GIBCO Life Technologies (Eggenstein, Germany); fura 2-AM was from Molecular Probes (Leiden, The Netherlands); polyvinylidene difluoride was from Millipore (Eschborn, Germany); dithiothreitol, phenylmethylsulfonyl fluoride, and thioglycolate were from Sigma Chemical. All other chemicals were of the best available quality, usually analytical grade.

Statistical analysis. Data are given as means ± SD of n = 6 experiments using independent cell preparations. Statistical analysis of data was performed according to Student's unpaired t-test. Probability (P) values of <0.05 were considered significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of ATP on MLC phosphorylation and [Ca2+]i. Addition of 10 µM ATP reduced MLC phosphorylation of aortic endothelial monolayers from a basal level of 36 ± 4% of total MLC to 6 ± 3% within 20 min (Fig. 1). The onset of MLC dephosphorylation coincided with the ATP-induced rise in [Ca2+]i. ATP (5-100 µM) reduced the level of net MLC phosphorylation in a concentration-dependent manner (Fig. 2).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of ATP on cytosolic Ca2+ concentration ([Ca2+]i) and myosin light chain (MLC) phosphorylation of aortic endothelial monolayers. A: increase in [Ca2+]i in response to ATP (10 µM). A representative single recording is shown. B: MLC dephosphorylation in response to ATP (10 µM). Means ± SD of n = 5 separate experiments of independent cell preparations are given. At time >= 1 min, MLC phosphorylation was significantly different from control (P < 0.05). C: Western blot analysis of MLC of endothelial cells exposed to ATP (10 µM) at time 0 and at 1, 10, 20, and 30 min. To enhance net dephosphorylation of MLC, endothelial cells were exposed to ML-7 (100 µM for 30 min), an inhibitor of MLC kinase. To induce net phosphorylation of MLC, cells were exposed to calyculin A (Caly; 10 nM for 60 min), an inhibitor of phosphatases. A blot of a representative experiment is given. The bands represent, from top to bottom, the nonphosphorylated (MLC), monophosphorylated (MLC~P), and diphosphorylated (MLC~PP) MLC, respectively.



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Dose-dependent effect of ATP on endothelial MLC phosphorylation. Data are means ± SD of n = 5 separate experiments of independent cell preparations. At time >= 1 min, MLC phosphorylation was significantly different from control (P < 0.05).

To test whether the effect of ATP on MLC dephosphorylation is, in part, transmitted via adenosine receptors, 8-phenyltheophylline (8-PT), an adenosine receptor antagonist, was applied. Presence of 8-PT (10 µM) left the reduction of MLC phosphorylation by ATP (10 µM) unchanged: 4 ± 3% after 20 min (not sigificant vs. ATP alone). 8-PT alone had no effect on MLC phosphorylation (not shown). Addition of adenosine (10 µM) also reduced MLC phosphorylation within 20 min to 5 ± 3%. This effect was inhibited in the presence of 8-PT (10 µM): 32 ± 5% MLC phosphorylation after 20 min in the presence of 8-PT plus ATP. Adenosine did not change [Ca2+]i (not shown).

Effects of Ca2+ chelation, ML-7, and calyculin A on MLC phosphorylation in the absence of ATP. First, it was tested whether intracellular Ca2+ chelation influences MLC phosphorylation under basal conditions. For that purpose, the cells were loaded with the Ca2+ chelator BAPTA-AM (10 µM) (Fig. 3). When endothelial cells were incubated in the presence of the chelator, MLC became progressively dephosphorylated. This finding indicates that under basal conditions MLC phosphorylation is regulated in a Ca2+-dependent manner.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of intracellular Ca2+ chelation on endothelial MLC phosphorylation under basal conditions. Endothelial cells were incubated in an extracellular medium containing 1.2 mM Ca2+ (control) or in the presence of 1.2 mM extracellular Ca2+ plus 10 µM 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA). Data are means ± SD of n = 5 separate experiments of independent cell preparations. At time >= 5 min, MLC phosphorylation was significantly different from control (P < 0.05).

Second, it was tested whether ML-7, an inhibitor of MLC kinase, affects the basal state of MLC phosphorylation. Addition of ML-7 (10-100 µM) caused a dose-dependent reduction of MLC phosphorylation (Fig. 4). At 100 µM ML-7, MLC became completely dephosphorylated within 10 min. This finding indicates that MLC kinase contributes actively to the basal state of MLC phosphorylation.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Dose-dependent effect of MLC kinase inhibitor ML-7 on endothelial MLC phosphorylation under basal conditions. A: data are means ± SD of n = 5 separate experiments of independent cell preparations. At time >= 1 min, MLC phosphorylation was significantly different from control (P < 0.05). B: Western blot analysis of MLC of endothelial cells exposed to ML-7 (100 µM) at time 0 and at 1, 10, 20, and 30 min. A blot of a representative experiment is given. The bands represent, from top to bottom, the nonphosphorylated (MLC), monophosphorylated (MLC~P), and the diphosphorylated (MLC~PP) MLC, respectively.

Third, it was tested whether an inhibitor of protein phosphatases influences MLC phosphorylation under basal conditions. The effects of calyculin A (1-10 nM), an inhibitor of PP-1 and PP-2A isoenzymes (9), was analyzed. As shown in Fig. 5, the inhibitor caused an increase in MLC phosphorylation in a dose-dependent manner. This finding indicates that the basal state of MLC phosphorylation is also influenced by protein phosphatase activity.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Dose-dependent effect of protein phosphatase inhibitor calyculin A on endothelial MLC phosphorylation under basal conditions. Data are means ± SD of n = 5 separate experiments of independent cell preparations. * P < 0.05 vs. control. Because MLC can become diphosphorylated, MLC phosphorylation varies between 0 and 200% (see Determination of MLC phosphorylation in MATERIALS AND METHODS).

Effect of ATP on MLC phosphorylation in the presence of xestospongin C. It was studied whether the ATP-induced net dephosphorylation of MLC is triggered by the concomitant increase in the ATP-induced rise in [Ca2+]i. To test this, endothelial cells were incubated for 20 min in the presence of xestospongin C (10 µM), an inhibitor of the inositol trisphosphate (IP3)-stimulated Ca2+ release from endoplasmic reticulum, before ATP (10 µM) was added to the cells. If the ATP-induced MLC dephosphorylation is Ca2+ independent, ATP will induce dephosphorylation of MLC also under those conditions, which prevent the ATP-induced Ca2+-release. As shown in Fig. 6, pretreatment with xestospongin C abolished the ATP-induced rise in [Ca2+]i but did not affect the ATP-induced reduction of MLC phosphorylation (Fig. 7). These results indicate that the ATP-induced MLC dephosphorylation is Ca2+ independent.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of xestospongin C (Xe C) on ATP-induced increase of [Ca2+]i in aortic endothelial cells. Control cells (open circle ) were exposed to neither ATP nor xestospongin C. Other cells were exposed to xestospongin C (10 µM; triangle ) for 20 min before additional administration of ATP (10 µM; black-triangle). Results were compared with effects of ATP alone (10 µM; ). Means ± SD of n = 5 separate experiments of independent cell preparations are given. * P < 0.05 vs. control.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of xestospongin C on ATP-induced endothelial MLC phosphorylation. Control cells (open circle ) were exposed to neither ATP nor xestospongin C. Other cells were exposed to xestospongin C (10 µM; triangle ) for 20 min before additional administration of ATP (10 µM; black-triangle). Results were compared with effects of ATP alone (10 µM; ). Means ± SD of n = 5 separate experiments of independent cell preparations are given. At time >= 1 min, MLC phosphorylation in the presence of ATP alone or ATP plus xestospongin C was significantly different from control (P < 0.05). MLC phosphorylation in the presence of ATP plus xestospongin C was not significantly different compared with MLC phosphorylation in the presence of ATP alone.

Effect of ATP on MLC phosphorylation in calyculin A-pretreated cells. As shown in the preceding section, ATP given alone caused a net dephosphorylation of MLC. Now, it was analyzed whether ATP influences MLC phosphorylation also in the presence of a protein phosphatase inhibitor, i.e., 10 nM calyculin A. ATP (10 µM) was added 15 min after the addition of calyculin A, when MLC phosphorylation had started to rise, indicating the inhibitory action of calyculin A (Fig. 8). In contrast to its effect when given alone, ATP enhanced MLC phosphorylation in cells pretreated with a phosphatase inhibitor. The results indicate that ATP also activates a MLC kinase activity that only becomes apparent, however, when the predominant phosphatase activation is prevented.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 8.   Influence of ATP on endothelial MLC phosphorylation in the presence of protein phosphatase inhibitor calyculin A. Control cells (open circle ) were exposed to neither ATP nor calyculin A. Endothelial cells were exposed to calyculin A (10 nM; ). Where indicated, ATP (10 µM; black-triangle) was added to the calyculin A-treated cells. Data are means ± SD of n = 5 separate experiments of independent cell preparations. At time >= 10 min, MLC phosphorylation in the presence of calyculin A alone was significantly different from control (P < 0.05). * P < 0.05 vs. calyculin A alone. Because MLC can become diphosphorylated, MLC phosphorylation varies between 0 and 200% (see Determination of MLC phosphorylation in MATERIALS AND METHODS).

Effect of ATP plus calyculin A on MLC phosphorylation in Ca2+-depleted cells. It was tested whether the ATP-induced stimulation of MLC phosphorylation in the presence of calyculin A depends on [Ca2+]i. For this purpose, endothelial cells were incubated in the presence of both BAPTA and calyculin A (Fig. 9). Under these conditions, ATP no longer increased MLC phosphorylation, indicating that the MLC kinase activity stimulated by ATP is Ca2+ dependent.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 9.   Influence of ATP on endothelial MLC phosphorylation in the presence of BAPTA and calyculin A. open circle , Control cells. In a set of experiments, endothelial cells were loaded with BAPTA (10 µM; ) for 20 min as in Fig. 3, and then ATP (10 µM; triangle ), calyculin A (10 nM; ), or ATP and calyculin A () were added. Data are means ± SD of n = 5 separate experiments of independent cell preparations. At time >= 10 min, MLC phosphorylation in the presence of BAPTA alone was significantly different from control (P < 0.05). At time >= 20 min, MLC phosphorylation in the presence of BAPTA + ATP, BAPTA + calyculin A or BAPTA + ATP + calyculin A was not significantly different compared with MLC phosphorylation in the presence of BAPTA alone (P > 0.05).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

This is the first study to analyze the effect of the physiological mediator ATP on the phosphorylation state of MLC, the regulatory protein of the contractile machinery in endothelial cells. The major finding is that ATP simultaneously stimulates a functional antagonism toward phosphorylation and dephosphorylation of MLC, in which the dephosphorylation of MLC prevails. Protein kinase activation is caused by the rise in cytosolic Ca2+ elicited by ATP; activation of MLC dephosphorylation is a Ca2+-independent effect of ATP.

Under basal culture conditions, MLC of porcine aortic endothelial cells was found to be partially phosphorylated. Exposure of these cells to an inhibitor of MLC kinase (ML-7) quickly reduced the extent of MLC phosphorylation. This indicates that under basal conditions, MLC kinase is one of the factors determining the state of MLC phosphorylation. The observation that intracellular Ca2+ chelation can mimic the effect of ML-7 indicates that the Ca2+/calmodulin-dependent MLC kinase is involved in phosphorylation of MLC under basal conditions. Exposure of the endothelial cells to the specific inhibitor of the protein phosphatases PP-1 and PP-2A, calyculin A, resulted in a rapid increase in the phosphorylation state of MLC. This result shows that under basal conditions the level of MLC phosphorylation is also controlled by protein phosphatases. Under basal conditions, MLC phosphorylation is thus in a steady state in which the action of MLC kinase is balanced by myosin phosphatases.

Exposure of endothelial cells to ATP caused a fast reduction of MLC phosphorylation. The ATP metabolite adenosine also induced dephosphorylaion of MLC. However, the effect of ATP is not mediated by its metabolite, as the action of adenosine but not the one of ATP can be blunted by the adenosine receptor inhibitor 8-PT.

ATP acts on MLC phosphorylation in a dose-dependent manner. This effect persisted for over 20 min. When protein phosphatases were first inhibited by calyculin A and ATP was then applied, it caused an (additional) increment in MLC phosphorylation instead of dephosphorylation. This latter experiment demonstrates that ATP also stimulates a protein kinase acting on the MLC. The finding that ATP, when applied alone, causes a net dephosphorylation must therefore be explained by a strong activation of protein phosphatases overruling the activation of protein kinase. It was tested whether the activation of protein phosphatase, acting on MLC, was Ca2+ dependent. The inhibitor of IP3-regulated Ca2+ release, xestospongin C (5, 15), was used to abolish the ATP-induced rise in [Ca2+]i. Under these conditions, a dephosphorylation of MLC in response to ATP was still observed. This shows that the calyculin A-sensitive protein phosphatases activated by ATP are Ca2+ independent. This is in accordance with previous findings that these endothelial cells express constitutively the Ca2+-independent phosphatase isoforms PP-1 and PP-2A (3, 10, 24), which are specifically inhibited by calyculin A at 10 nM (9). Recently, Verin et al. (22) found that endothelial cells can also express the (inducible) Ca2+/calmodulin-dependent protein phosphatase type 2B, which can contribute to the control of MLC dephosphorylation in the presence of thrombin.

It was also tested whether the protein kinase activated by ATP depends on the ATP-induced Ca2+ rise. For this purpose, endothelial cells were first Ca2+ depleted and then ATP and calyculin A were added simultaneously. The fact that, under this condition, ATP no longer caused an increase in MLC phosphorylation shows that the ATP-induced activation of protein kinase is indeed dependent on the Ca2+ rise. ATP stimulates both a phosphorylation of MLC by a Ca2+-dependent activation of MLC kinase and a dephosphorylation of MLC by Ca2+-independent protein phosphatases. The dephosphorylation prevails.

In endothelial cells, as in cells from other tissues, little is known about signal transduction leading to activation of myosin phosphatases. Activation of PP-1 and PP-2A could be due to reduction of basal Rho kinase activation, since the latter is part of an inhibitory mechanism (4). In smooth muscle cells, PP-1 and PP-2A are also activated via protein kinase A or G (1, 21), by mechanisms that have not been fully analyzed. Further work is required to clarify whether ATP activates myosin phosphatase through one of these or yet another mechanism.

The results of this study are of particular interest for two main reasons. First, they describe a novel effect of ATP on endothelial cells. ATP is an important vascular mediator. Its extracellular concentration is normally kept low by ectonucleotidases (7, 28) but may increase substantially at the sites of thrombus formation (11) in hypoxic myocardium (2) or close to ATP-releasing nerve endings. The present findings also explain why ATP was found to reduce endothelial barrier permeability despite a cytosolic Ca2+ rise (16). Second, ATP is one of the few known physiological mediators and the first described for endothelial cells that strongly induces MLC dephosphorylation. The results of this study indicate that this effect is due to an activation of myosin phosphatases. The vast majority of other physiological mediators investigated in smooth muscle cells acts through an inhibition mechanism if affecting myosin phosphatases. The identification of a physiological mechanism of myosin phosphatase activation is of particular interest for endothelial pathophysiology as its knowledge may lead to new therapeutic principles for stabilizing the endothelial barrier by dephosphorylation of endothelial MLC.


    ACKNOWLEDGEMENTS

This work was supported by the Deutsche Forschungsgemeinschaft, grant A3 and A4 of SFB 547.


    FOOTNOTES

This work is a part of the thesis submitted by U. Schavier-Schmitz.

Address for reprint requests and other correspondence: T. Noll, Physiologisches Institut, Justus-Liebig-Universität, Aulweg 129, D-35392 Giessen Germany (E-mail: thomas.noll{at}physiologie.med.uni-giessen.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Received 17 December 1999; accepted in final form 29 March 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Arner, A, and Pfitzer G. Regulation of cross-bridge cycling by Ca2+ in smooth muscle. Rev Physiol Biochem Pharmacol 134: 63-146, 1999[Medline].

2.   Clemens, MG, and Forrester T. Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. J Physiol (Lond) 312: 143-158, 1981[Abstract].

3.   Diwan, AH, Honkanen RE, Schaeffer RCJ, Strada SJ, and Thompson WJ. Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells. J Cell Physiol 171: 259-270, 1997[ISI][Medline].

4.   Essler, MAM, Kruse H-J, Kaibuchi K, Weber PC, and Äpfelbacher M. Thrombin inactivates myosin light chain phosphatase via rho and its target rho kinase in human endothelial cells. J Biol Chem 273: 21867-21874, 1998[Abstract/Free Full Text].

5.   Gafni, J, Munsch JA, Lam TH, Catlin MC, Costa LG, Molinski TF, and Pessah IN. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 19: 723-733, 1997[ISI][Medline].

6.   Garcia, JG, Davis HW, and Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163: 510-522, 1995[ISI][Medline].

7.   Gordon, JL. Extracellular ATP: effects, sources and fate. Biochem J 233: 309-319, 1986[ISI][Medline].

8.   Grynkiewicz, G, Poenie M, and Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985[Abstract].

9.   Ishihara, H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, and Hartshorne DJ. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159: 871-877, 1989[ISI][Medline].

10.   Knapp, J, Boknik P, Luss I, Huke S, Linck B, Lüss H, Müller FU, Müller T, Nacke P, Noll T, Piper HM, Schmitz W, Vahlensieck U, and Neumann J. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability. J Pharmacol Exp Ther 289: 1480-1486, 1999[Abstract/Free Full Text].

11.   Meyers, KM, Holmsen H, and Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol Renal Fluid Electrolyte Physiol 243: F454-F461, 1982.

12.   Moy, AB, Shasby SS, Scott BD, and Shasby DM. The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest 92: 1198-1206, 1993[ISI][Medline].

13.   Moy, AB, Van Engelenhoven J, Bodmer J, Kamath J, Keese C, Giaever I, Shasby S, and Shasby DM. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest 97: 1020-1027, 1996[Abstract/Free Full Text].

14.   Muhs, A, Noll T, and Piper HM. Vinculin phosphorylation and barrier failure of coronary endothelial monolayers under energy depletion. Am J Physiol Heart Circ Physiol 273: H608-H617, 1997[Abstract/Free Full Text].

15.   Narasimhan, K, Pessah IN, and Linden DJ. Inositol-1,4,5-trisphosphate receptor-mediated Ca2+ mobilization is not required for cerebellar long-term depression in reduced preparations. J Neurophysiol 80: 2963-2974, 1998[Abstract/Free Full Text].

16.   Noll, T, Hölschermann H, Koprek K, Gündüz D, Haberbosch W, Tillmanns H, and Piper HM. ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i. Am J Physiol Heart Circ Physiol 276: H1892-H1901, 1999[Abstract/Free Full Text].

17.   Persechini, A, Kamm KE, and Stull JT. Different phosphorylated forms of myosin in contracting tracheal smooth muscle. J Biol Chem 261: 6293-6299, 1986[Abstract/Free Full Text].

18.   Schnittler, HJ, Wilke A, Gress T, Suttorp N, and Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol (Lond) 431: 379-401, 1990[Abstract].

19.   Shasby, DM, Stevens T, Ries D, Moy AB, Kamath JM, Kamath AM, and Shasby SS. Thrombin inhibits myosin light chain dephosphorylation in endothelial cells. Am J Physiol Lung Cell Mol Physiol 272: L311-L319, 1997[Abstract/Free Full Text].

20.   Sheldon, R, Moy A, Lindsley K, Shasby S, and Shasby DM. Role of myosin light-chain phosphorylation in endothelial cell retraction. Am J Physiol Lung Cell Mol Physiol 265: L606-L612, 1993[Abstract/Free Full Text].

21.   Somlyo, AP, Xuqiong W, Walker LA, and Somlyo AV. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 134: 203-234, 1999.

22.   Verin, AD, Cooke C, Herenyiova M, Patterson CE, and Garcia JG. Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses. Am J Physiol Lung Cell Mol Physiol 275: L788-L799, 1998[Abstract/Free Full Text].

23.   Verin, AD, Gilbert-McClain LI, Patterson CE, and Garcia JG. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol 19: 767-776, 1998[Abstract/Free Full Text].

24.   Verin, AD, Patterson CE, Day MA, and Garcia JG. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol Lung Cell Mol Physiol 269: L99-L108, 1995[Abstract/Free Full Text].

25.   Watanabe, H, Kuhne W, Schwartz P, and Piper HM. A2-adenosine receptor stimulation increases macromolecule permeability of coronary endothelial cells. Am J Physiol Heart Circ Physiol 262: H1174-H1181, 1992[Abstract/Free Full Text].

26.   Wysolmerski, RB, and Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 87: 16-20, 1990[Abstract].

27.   Wysolmerski, RB, and Lagunoff D. Regulation of permeabilized endothelial cell retraction by myosin phosphorylation. Am J Physiol Cell Physiol 261: C32-C40, 1991[Abstract/Free Full Text].

28.   Zimmermann, H. 5'-Nucleotidase: molecular structure and functional aspects. Biochem J 285: 345-365, 1992[ISI][Medline].


Am J Physiol Cell Physiol 279(3):C717-C723
0363-6143/00 $5.00 Copyright © 2000 the American Physiological Society